NEW YORK – Proscia said on Tuesday that it will collaborate with Johns Hopkins School of Medicine on the development of computational applications that incorporate artificial intelligence to advance the practice of pathology for multiple diseases.
Terms of the agreement were not disclosed.
The collaboration adds to a number of academic and commercial institutions that Proscia is working with to bring disease-specific AI applications to market, the firm said.
Training a successful AI system for pathology requires diverse, high-quality pathology data so that the system is accurate across a wide variety of diseases, methods of biopsy, preparation of tissue, tissue-dying procedures, and digital scanning processes.
Starting with its release of DermAI in June 2019 for research use, Proscia has grown its number of collaborators to include the University of Florida, Cockerell Dermatopathology, Dermatopathology Laboratory of Central States, and Thomas Jefferson University Hospital. DermAI, a module on the firm's Concentriq digital platform, uses deep learning to prescreen and classify skin biopsies, aiming to help reduce diagnostic errors and improve laboratory quality and efficiency.
Last month, Proscia announced that it is working with Dell Technologies to provide a scalable IT infrastructure for deploying digital pathology solutions. Proscia recently received CE marking for its Concentriq Dx digital pathology software for use in primary diagnosis.